In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1835 News Items found
MSK-ACCESS Receives New York State Approval for New Molecular Assay

Memorial Sloan Kettering Cancer Center (MSK) today announced that the New York State Department of Health has issued approval for a new molecular assay, Analysis of Circulating cfDNA to Evaluate Somatic Status (MSK-ACCESS).  MSK-ACCESS was developed within the Marie-Josee and Henry R. Kravis Center for Molecular Oncology (CMO) and the test has been clinically validated and implemented by members of MSK’s Molecular Diagnostics Service.
In the Lab
Two clusters of colored blobs with a diagram in the middle
Computational “Hive Mind” Helps Scientists Solve an Enzyme’s Cryptic Movements

The breakthrough gives an unprecedented look at the varied and shifting poses of a protein in action.
Roundup
People milling about at the 2019 ASCO meeting
Highlights from ASCO 2019: A Low-Fat Diet and Breast Cancer Risk, Targeted Therapy for Salivary Gland Tumors, and More

Read about a few of the MSK studies being presented at the 2019 American Society of Clinical Oncology's annual meeting.
Roundup
Crowd shot at ASCO 2019
Highlights from ASCO 2019: Progress in Treating Cancer in Children

MSK Kids doctors report advances in treating pediatric cancers at the 2019 meeting of the American Society of Clinical Oncology.
In the News
MSK medical oncologist Eileen O'Reilly with a patient
ASCO 2019: PARP Inhibitors Benefit People with Pancreatic Cancer Who Have a BRCA Mutation

Results from a large phase III clinical trial unveiled at this year’s ASCO meeting identify an effective targeted therapy for a subset of people with pancreatic cancer.
Q&A
Medical oncologist William Tap
What Can Be Learned from a Negative Clinical Trial? Findings from a Sarcoma Study at ASCO 2019

At the ASCO meeting in Chicago, MSK medical oncologist William Tap talked about disappointing results from a new sarcoma drug, which didn’t increase survival.
Event
The GSK class of 2019
Convocation and Commencement Ceremony Celebrates Scientists and Scholars from MSK and Beyond

Scientists and scholars received degrees and awards at MSK's 40th annual ceremony, held on May 29.
In the Clinic
Conceptual orange-and-green-colored X-ray showing cancer of the bladder.
Prestigious Grant Bolsters Bladder Cancer Research at MSK

A prominent research grant will enable MSK doctors and scientists to advance the treatment of bladder cancer.
Q&A
scale
Why Are More Young Adults Getting Cancer? Obesity May Be to Blame

Cancer among younger Americans is on the rise, and much of it is linked to obesity. An MSK expert on diet and cancer explains what’s behind this disturbing new trend.
MSK Research and Experts at the 2019 ASCO Annual Meeting: Caring for Every Patient, Learning from Every Patient

More than 30,000 oncology professionals from around the world will gather in Chicago from May 31 to June 4 for the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting. For more information and to set up interviews, email [email protected]. Follow the meeting live on Twitter using the hashtag #ASCO19 and follow MSK on Twitter at @sloan_kettering.